{"id":"https://openalex.org/W3213326536","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.506","title":"506 IGNYTE: an open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 \u00b1 nivolumab in patients with advanced solid tumors","display_name":"506 IGNYTE: an open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 \u00b1 nivolumab in patients with advanced solid tumors","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3213326536","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.506","mag":"3213326536"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2021-sitc2021.506","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.506","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.506","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A538.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A538.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051430596","display_name":"Mark Ross Middleton","orcid":"https://orcid.org/0000-0003-0167-1685","observed_orcids":["https://orcid.org/0000-0003-0167-1685"]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Middleton","raw_affiliation_strings":["Churchill Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Churchill Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2801179840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089777560","display_name":"Mohammed M. Milhem","orcid":"https://orcid.org/0000-0003-4663-6824","observed_orcids":["https://orcid.org/0000-0003-4663-6824"]},"institutions":[{"id":"https://openalex.org/I4390039339","display_name":"University of Iowa Holden Comprehensive Cancer Center","ror":"https://ror.org/01jhe7086","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I126307644","https://openalex.org/I4390039339"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammed Milhem","raw_affiliation_strings":["Holden Comprehensive Cancer Center, Iowa City, IA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Holden Comprehensive Cancer Center, Iowa City, IA, USA","institution_ids":["https://openalex.org/I4390039339"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007751483","display_name":"Francesca Aroldi","orcid":"https://orcid.org/0000-0002-1202-0258","observed_orcids":["https://orcid.org/0000-0002-1202-0258"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Francesca Aroldi","raw_affiliation_strings":["University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075295348","display_name":"Joseph J. Sacco","orcid":"https://orcid.org/0000-0003-2591-9796","observed_orcids":["https://orcid.org/0000-0003-2591-9796"]},"institutions":[{"id":"https://openalex.org/I283776267","display_name":"Clatterbridge Cancer Centre NHS Foundation Trust","ror":"https://ror.org/05gcq4j10","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I283776267"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joseph Sacco","raw_affiliation_strings":["Clatterbridge Cancer Centre, Wirral, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clatterbridge Cancer Centre, Wirral, UK","institution_ids":["https://openalex.org/I283776267"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038120683","display_name":"Ari M. Vanderwalde","orcid":"https://orcid.org/0000-0002-6842-2563","observed_orcids":["https://orcid.org/0000-0002-6842-2563"]},"institutions":[{"id":"https://openalex.org/I4210108188","display_name":"West Cancer Center","ror":"https://ror.org/01jkda844","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210108188"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ari VanderWalde","raw_affiliation_strings":["West Cancer Center and Research Institute, Germantown, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"West Cancer Center and Research Institute, Germantown, TN, USA","institution_ids":["https://openalex.org/I4210108188"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050423968","display_name":"Scott L. Baum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108188","display_name":"West Cancer Center","ror":"https://ror.org/01jkda844","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210108188"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Baum","raw_affiliation_strings":["West Cancer Center and Research Institute, Germantown, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"West Cancer Center and Research Institute, Germantown, TN, USA","institution_ids":["https://openalex.org/I4210108188"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018551359","display_name":"Adel Samson","orcid":"https://orcid.org/0000-0002-3081-7850","observed_orcids":["https://orcid.org/0000-0002-3081-7850"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adel Samson","raw_affiliation_strings":["University of Leeds, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Leeds, Leeds, UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086165685","display_name":"Jason Alan Chesney","orcid":"https://orcid.org/0000-0003-0217-8278","observed_orcids":["https://orcid.org/0000-0003-0217-8278"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Chesney","raw_affiliation_strings":["James Graham Brown Cancer Center, Louisville, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"James Graham Brown Cancer Center, Louisville, KY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042731311","display_name":"Jiaxin Niu","orcid":"https://orcid.org/0000-0001-9018-287X","observed_orcids":["https://orcid.org/0000-0001-9018-287X"]},"institutions":[{"id":"https://openalex.org/I4387154023","display_name":"Banner MD Anderson Cancer Center","ror":"https://ror.org/049c9q337","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802412784","https://openalex.org/I4387154023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiaxin Niu","raw_affiliation_strings":["Banner MD Anderson Cancer Center, Gilbert, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Banner MD Anderson Cancer Center, Gilbert, AZ, USA","institution_ids":["https://openalex.org/I4387154023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012636282","display_name":"Terence Duane Rhodes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108785884","display_name":"Intermountain Healthcare","ror":"https://ror.org/04mvr1r74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I108785884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terence Rhodes","raw_affiliation_strings":["Intermountain Med Ctr, St. George, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intermountain Med Ctr, St. George, UT, USA","institution_ids":["https://openalex.org/I108785884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055706456","display_name":"Tawnya Lynn Bowles","orcid":"https://orcid.org/0000-0002-1883-1510","observed_orcids":["https://orcid.org/0000-0002-1883-1510"]},"institutions":[{"id":"https://openalex.org/I108785884","display_name":"Intermountain Healthcare","ror":"https://ror.org/04mvr1r74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I108785884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tawnya Bowles","raw_affiliation_strings":["Intermountain Med Ctr, St. George, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intermountain Med Ctr, St. George, UT, USA","institution_ids":["https://openalex.org/I108785884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023616396","display_name":"Hamid Emamekhoo","orcid":"https://orcid.org/0000-0002-8506-8703","observed_orcids":["https://orcid.org/0000-0002-8506-8703"]},"institutions":[{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hamid Emamekhoo","raw_affiliation_strings":["Carbone Cancer Center, Madison, WI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carbone Cancer Center, Madison, WI, USA","institution_ids":["https://openalex.org/I4210103341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088042471","display_name":"Katy K. Tsai","orcid":"https://orcid.org/0000-0002-7705-1813","observed_orcids":["https://orcid.org/0000-0002-7705-1813"]},"institutions":[{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katy Tsai","raw_affiliation_strings":["Helen Diller Family Comprehensive Cancer, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer, San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024943710","display_name":"Gino In","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gino In","raw_affiliation_strings":["Norris Comprehensive Cancer Center, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norris Comprehensive Cancer Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I4210117038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050528758","display_name":"Georgia Marie Beasley","orcid":"https://orcid.org/0000-0001-6387-9030","observed_orcids":["https://orcid.org/0000-0001-6387-9030"]},"institutions":[{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Georgia Beasley","raw_affiliation_strings":["Duke Cancer Institute, DURHAM, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute, DURHAM, NC, USA","institution_ids":["https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039301683","display_name":"Bartosz Chmielowski","orcid":"https://orcid.org/0000-0002-2374-3320","observed_orcids":["https://orcid.org/0000-0002-2374-3320"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bartosz Chmielowski","raw_affiliation_strings":["University of California Los Angeles, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Los Angeles, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029900243","display_name":"Sophie Dalac","orcid":"https://orcid.org/0000-0002-9101-3119","observed_orcids":["https://orcid.org/0000-0002-9101-3119"]},"institutions":[{"id":"https://openalex.org/I4210116240","display_name":"CHU Dijon Bourgogne","ror":"https://ror.org/0377z4z10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116240"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sophie Dalac-Rat","raw_affiliation_strings":["CHU Dijon Bourgogne, Bourgogne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Dijon Bourgogne, Bourgogne, France","institution_ids":["https://openalex.org/I4210116240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031315234","display_name":"Katharina Charlotte K\u00e4hler","orcid":"https://orcid.org/0000-0001-9953-0893","observed_orcids":["https://orcid.org/0000-0001-9953-0893"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Katharina Kahler","raw_affiliation_strings":["University of Kiel, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kiel, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058294413","display_name":"Eva Mu\u00f1oz\u2010Couselo","orcid":"https://orcid.org/0000-0001-7556-7608","observed_orcids":["https://orcid.org/0000-0001-7556-7608"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eva Mu\u00f1oz","raw_affiliation_strings":["Vall d\u2019Hebron Hospital, Vall D\u2019hebron, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d\u2019Hebron Hospital, Vall D\u2019hebron, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070458650","display_name":"Anna Claire Olsson-Brown","orcid":"https://orcid.org/0000-0001-7721-5817","observed_orcids":["https://orcid.org/0000-0001-7721-5817"]},"institutions":[{"id":"https://openalex.org/I283776267","display_name":"Clatterbridge Cancer Centre NHS Foundation Trust","ror":"https://ror.org/05gcq4j10","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I283776267"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anna Olsson-Brown","raw_affiliation_strings":["Clatterbridge Cancer Centre, Wirral, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clatterbridge Cancer Centre, Wirral, UK","institution_ids":["https://openalex.org/I283776267"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087694927","display_name":"Praveen K. Bommareddy","orcid":"https://orcid.org/0000-0003-0089-8693","observed_orcids":["https://orcid.org/0000-0003-0089-8693"]},"institutions":[{"id":"https://openalex.org/I4405267747","display_name":"Replimune Group, Inc. (United States)","ror":"https://ror.org/045smfy07","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267747"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Praveen Bommareddy","raw_affiliation_strings":["Replimune, Woburn, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Replimune, Woburn, MA, USA","institution_ids":["https://openalex.org/I4405267747"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lavita Menezes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267747","display_name":"Replimune Group, Inc. (United States)","ror":"https://ror.org/045smfy07","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267747"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lavita Menezes","raw_affiliation_strings":["Replimune, Woburn, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Replimune, Woburn, MA, USA","institution_ids":["https://openalex.org/I4405267747"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020637647","display_name":"Andrea Pirzkall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267747","display_name":"Replimune Group, Inc. (United States)","ror":"https://ror.org/045smfy07","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267747"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Pirzkall","raw_affiliation_strings":["Replimune, Woburn, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Replimune, Woburn, MA, USA","institution_ids":["https://openalex.org/I4405267747"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109525259","display_name":"Robert S. Coffin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267747","display_name":"Replimune Group, Inc. (United States)","ror":"https://ror.org/045smfy07","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267747"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Coffin","raw_affiliation_strings":["Replimune, Woburn, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Replimune, Woburn, MA, USA","institution_ids":["https://openalex.org/I4405267747"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072284989","display_name":"Kevin Joseph Harrington","orcid":"https://orcid.org/0000-0002-6014-348X","observed_orcids":["https://orcid.org/0000-0002-6014-348X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kevin Harrington","raw_affiliation_strings":["The Institute of Cancer Research, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, UK","institution_ids":["https://openalex.org/I142947616"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":18,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A538","last_page":"A538"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5615000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5615000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.40310001373291016,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.009999999776482582,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-herpesvirus","display_name":"oncolytic herpesvirus","score":0.7319999933242798},{"id":"https://openalex.org/keywords/rp1","display_name":"RP1","score":0.8669999837875366},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9089999794960022},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7760000228881836},{"id":"https://openalex.org/keywords/cutaneous-squamous-cell-carcinoma","display_name":"cutaneous squamous cell carcinoma","score":0.8190000057220459},{"id":"https://openalex.org/keywords/cutaneous-melanoma","display_name":"cutaneous melanoma","score":0.8289999961853027},{"id":"https://openalex.org/keywords/non-melanoma-skin-cancer","display_name":"non-melanoma skin cancer","score":0.9129999876022339},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8709999918937683},{"id":"https://openalex.org/keywords/immunogenic-cell-death","display_name":"immunogenic cell death","score":0.7139999866485596},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.6420000195503235},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5109999775886536},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8545146584510803},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7387694120407104},{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.6408454775810242},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6398543119430542},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5957015752792358},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5279813408851624},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5179542303085327},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5088856220245361},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.4373071789741516},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.43401145935058594},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3590226173400879},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.28539004921913147}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2021-sitc2021.506","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.506","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.506","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A538.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:d5df803646ea41a1b37a9be032989313","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d5df803646ea41a1b37a9be032989313","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2021-sitc2021.506","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.506","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.506","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A538.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3213326536.pdf","grobid_xml":"https://content.openalex.org/works/W3213326536.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W2967139876"],"related_works":["https://openalex.org/W4206521406","https://openalex.org/W3204359623","https://openalex.org/W4221034077","https://openalex.org/W4281621888","https://openalex.org/W2947509133","https://openalex.org/W4415941225","https://openalex.org/W3030532195","https://openalex.org/W3123701916","https://openalex.org/W4379281040","https://openalex.org/W4400272142"],"abstract_inverted_index":{"Background":[0],"RP1":[1,25,51,107,216,282,316,356],"is":[2,96,268,369],"an":[3],"enhanced":[4],"potency":[5],"oncolytic":[6,422],"HSV-1":[7],"which":[8],"expresses":[9],"a":[10,77,97,195,419],"fusogenic":[11],"glycoprotein":[12],"(GALV-GP":[13],"R-)":[14],"and":[15,32,48,70,88,109,142,194,310,344,352,357,365,375,385,440],"granulocyte":[16],"macrophage":[17],"colony":[18],"stimulating":[19],"factor":[20],"(GM-CSF).1":[21],"In":[22],"pre-clinical":[23],"studies,":[24,359],"demonstrated":[26],"potent":[27],"GALV-GP":[28],"R-enhanced":[29],"anti-tumor":[30],"activity":[31],"immunogenic":[33],"cell":[34,85],"death.":[35],"This":[36,95],"Phase":[37],"1/2":[38],"(Ph":[39],"1/2)":[40],"study":[41,105,303,452],"was":[42,453,469],"designed":[43],"to":[44,92,156,176,212,265,277,305,389,474],"evaluate":[45],"the":[46,160,206,228,245,297,302,307,325,373,381,460],"safety":[47],"efficacy":[49],"of":[50,79,106,215,248,281,296,301,315,334,355,362,418],"\u00b1":[52],"nivolumab":[53],"(nivo)":[54],"in":[55,76,116,120,159,198,205,271,317,372,380,391],"patients":[56,472],"(pts)":[57],"with":[58,111,118,122,180,319,377],"advanced":[59,124],"solid":[60,125],"tumors,":[61],"including":[62,82,127,360],"pts":[63,121,153,179],"whose":[64],"disease":[65,339],"failed":[66,90,182,185,200,327],"prior":[67,132,473],"anti-PD-1/PD-L1":[68,133,181],"therapy":[69],"has":[71],"reported":[72],"promising":[73],"interim":[74],"data":[75],"number":[78],"tumor":[80,363],"types":[81],"cutaneous":[83,201],"squamous":[84],"carcinoma":[86],"(CSCC)":[87],"anti-PD1":[89,326],"melanoma":[91,168,202,328],"date.2":[93],"Methods":[94],"multi-center,":[98],"first-in-human,":[99],"open":[100,390],"label,":[101],"multi-cohort,":[102],"non-randomized":[103],"Ph1":[104],"alone":[108],"combined":[110],"nivo":[112,119,250],"followed":[113,237],"by":[114,238,321,455],"Ph2":[115],"combination":[117,144,318],"recurrent":[123],"tumors":[126,187],"those":[128],"that":[129],"progressed":[130],"after":[131],"therapy.":[134],"The":[135,293,451],"Ph":[136,162,207,230,298],"1":[137,236],"monotherapy":[138],"dose":[139,232,247],"escalation":[140],"(n=14)":[141],"RP-1":[143],"expansion":[145],"(n=22)":[146],"cohorts":[147],"are":[148,154,290,304,387],"fully":[149],"enrolled.":[150],"Approximately":[151],"260":[152],"expected":[155,388],"be":[157],"enrolled":[158],"ongoing":[161,371],"2":[163,208,231,266,299],"portion":[164,209],"across":[165],"five":[166],"cohorts;":[167],"(n=30,":[169],"enrollment":[170],"complete),":[171],"non-melanoma":[172],"skin":[173],"cancer":[174,192],"(n=45,":[175],"include":[177,332,350],"15":[178],"disease),":[183],"anti-PD-1":[184,199],"MSI-H/dMMR":[186],"(n=30),":[188],"anti-PD-1/PD-L1-failed":[189],"non-small-cell":[190],"lung":[191],"(n=30)":[193],"registration-directed":[196],"cohort":[197],"(n=125).":[203],"Pts":[204,273],"receive":[210,275],"up":[211,264,276],"10":[213],"mL":[214],"intratumorally":[217],"into":[218],"one":[219],"or":[220,223,459],"more":[221],"superficial":[222],"deep":[224],"seated/visceral":[225],"lesions":[226],"at":[227,464],"recommended":[229],"(1x10^6":[233],"PFU/mL":[234,240],"\u00d7":[235,241],"1x10^7":[239],"7,":[242],"Q2W).":[243],"Following":[244],"first":[246],"RP1,":[249],"(240":[251],"mg":[252,260],"IV":[253,261],"Q2W":[254],"for":[255,263,324],"4":[256],"months":[257],"then":[258],"480":[259],"Q4W":[262],"years)":[267],"subsequently":[269],"administered":[270],"combination.":[272],"may":[274],"8":[278],"additional":[279,378],"doses":[280],"if":[283],"they":[284],"meet":[285],"protocol-specified":[286],"criteria.":[287],"Tumor":[288],"assessments":[289],"performed":[291],"Q8W.":[292],"primary":[294],"objectives":[295,331,349],"part":[300],"assess":[306],"safety,":[308],"tolerability,":[309],"overall":[311],"response":[312,337],"rate":[313],"(ORR)":[314],"nivo,":[320],"independent":[322],"review":[323,457],"cohort.":[329],"Secondary":[330],"duration":[333],"response,":[335],"complete":[336],"rate,":[338,341],"control":[340],"PFS,":[342],"1-year":[343],"2-year":[345],"survival":[346],"rates.":[347],"Exploratory":[348],"biodistribution":[351],"shedding":[353],"analysis":[354],"biomarker":[358],"analyses":[361],"biopsies":[364],"blood":[366],"samples.":[367],"Enrollment":[368],"currently":[370],"UK":[374],"US,":[376],"sites":[379],"EU":[382],"(including":[383],"France":[384],"Spain)":[386],"2021.":[392],"Trial":[393],"Registration":[394],"NCT03767348":[395],"References":[396],"Thomas":[397],"S,":[398],"Kuncheria":[399],"L,":[400],"Roulstone":[401],"V,":[402],"Kyula":[403],"JN,":[404],"Mansfield":[405],"D,":[406],"Bommareddy":[407],"PK,":[408],"Smith":[409],"H,":[410],"Kaufman":[411],"HL,":[412],"Harrington":[413],"KJ,":[414],"Coffin":[415,436],"RS.":[416],"Development":[417],"new":[420],"fusion-enhanced":[421],"immunotherapy":[423],"platform":[424],"based":[425],"on":[426],"herpes":[427],"simplex":[428],"virus":[429],"type":[430],"1.":[431],"J":[432],"Immunother":[433],"Cancer":[434],"2019;7(1):214.":[435],"R,":[437],"Astley-Sparke":[438],"P,":[439],"Middleton":[441],"M":[442],"(2021,":[443],"June":[444],"3rd).":[445],"Retrieved":[446],"from":[447,471],"https://ir.replimune.com/static-files/f4fe3349-e082-4d41-94a1-106ce7e78a23":[448],"Ethics":[449],"Approval":[450],"approved":[454],"institutional":[456],"board":[458],"local":[461],"ethics":[462],"committee":[463],"each":[465],"site.":[466],"Informed":[467],"consent":[468],"obtained":[470],"enrollment.":[475]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2021-11-22T00:00:00"}